# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-24-090524
Filing Date
2024-10-25
Accepted
2024-10-25 08:07:42
Documents
17
Period of Report
2024-10-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea0218381-8k_elevai.htm iXBRL | 8-K | 31851
2 | MASTER SERVICES AGREEMENT BETWEEN ELEVAI BIOSCIENCES INC. AND KCRN RESEARCH, INC | ea021838101ex10-1_elevai.htm | EX-10.1 | 59957
3 | WORK ORDER NUMBER 1 DATED OCTOBER 21, 2024 | ea021838101ex10-2_elevai.htm | EX-10.2 | 1805
4 | GRAPHIC | ex10-2_001.jpg | GRAPHIC | 316327
5 | GRAPHIC | ex10-2_002.jpg | GRAPHIC | 254795
| Complete submission text file | 0001213900-24-090524.txt |  | 1070261

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | elab-20241021.xsd | EX-101.SCH | 3033
7 | XBRL LABEL FILE | elab-20241021_lab.xml | EX-101.LAB | 34240
8 | XBRL PRESENTATION FILE | elab-20241021_pre.xml | EX-101.PRE | 22371
19 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0218381-8k_elevai_htm.xml | XML | 3795

Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 241394335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)